Christopher Slapak
2020
In 2020, Christopher Slapak earned a total compensation of $1.2M as Chief Medical Officer at Vor Biopharma.
Compensation breakdown
| Non-Equity Incentive Plan | $136,800 |
|---|---|
| Option Awards | $627,356 |
| Salary | $176,846 |
| Other | $283,344 |
| Total | $1,224,346 |
Slapak received $627.4K in option awards, accounting for 51% of the total pay in 2020.
Slapak also received $136.8K in non-equity incentive plan, $176.8K in salary and $283.3K in other compensation.
Rankings
In 2020, Christopher Slapak's compensation ranked 7,748th out of 13,090 executives tracked by ExecPay. In other words, Slapak earned more than 40.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,748 out of 13,090 | 41st |
Division Manufacturing | 3,267 out of 5,621 | 42nd |
Major group Chemicals And Allied Products | 1,323 out of 2,254 | 41st |
Industry group Drugs | 1,146 out of 1,954 | 41st |
Industry Biological Products, Except Diagnostic Substances | 272 out of 411 | 34th |
Source: SEC filing on April 28, 2022.
Slapak's colleagues
We found two more compensation records of executives who worked with Christopher Slapak at Vor Biopharma in 2020.